{name}
{subtitle}
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
city
~14 mi. (Nürnberg, Germany, +226 more cities)
facility
Universitaetsklinik der Paracelsus Medizinischen Privatuniversitaet ( Site 0318)
drug
enzalutamide, +1 more drug
drug type
hormone therapy, +1 more type
A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer
city
~16 mi. (Erlangen, Germany, +192 more cities)
facility
Universitätsklinikum Erlangen
biomarker
ER Positive, +1 more biomarker
drug
abemaciclib, +1 more drug
drug type
hormone therapy, +1 more type
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
city
~16 mi. (Erlangen, Germany, +207 more cities)
facility
Universitaetsklinikum Erlangen ( Site 1001)
biomarker
ER Positive, +1 more biomarker
drug
cyclophosphamide, +6 more drugs
drug type
chemotherapy, +3 more types
Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)
city
~16 mi. (Erlangen, Germany, +159 more cities)
facility
Universitaetsklinikum Erlangen ( Site 0505)
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +1 more type
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)
city
~16 mi. (Erlangen, Germany, +145 more cities)
facility
Universitaetsklinikum Erlangen ( Site 1209)
drug
pembrolizumab, +1 more drug
drug type
immunotherapy, +2 more types
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
city
~28 mi. (Frankfurt, Germany, +199 more cities)
facility
Universitaetsklinikum Frankfurt ( Site 0467)
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
city
~28 mi. (Frankfurt, Germany, +150 more cities)
facility
Universitaetsklinikum Frankfurt ( Site 0403)
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +2 more types